| 26-L5 | murine colon adenocarcinoma cell line |
| 3T3-L1 | mouse embryonic fibroblast cell line |
| 4CL | 4-coumaroyl CoA ligase |
| A2780 | human ovarian cancer cell line |
| A375 | human melanoma cell line |
| A431 | epidermoid carcinoma cell line |
| A549 | adenocarcinomic human alveolar basal epithelial cell line |
| A5490 | airway epithelial cells and mitochondrial DNA depleted cancer cell line |
| AKT | serine/threonine-specific protein kinase (PKB) |
| AP-1 | transcription factor |
| APN | aminopeptidase N |
| ATF3 | Activating Transcription Factor 3 |
| AUXB1 | wild type of chinese hamster ovary cells, CHO |
| B16-BL6 | murine melanoma cell line |
| B16F0 | murine melanoma cell line, parent cells |
| B16F10 | murine melanoma cell line from a C57BL/6J mouse |
| Bad | Bcl2-associated agonist of cell death |
| Bax | Bcl-2-associated X protein |
| Bcl-2 | B-cell lymphoma 2 |
| Bcl-xL | B-cell lymphoma-extra large |
| BDDE | bis (2,3-dibromo-4,5-dihydroxybenzyl) ether |
| BDDPM | bis (2,3-dibromo-4,5-dihydroxy-phenyl)-methane |
| Bel7402 | human hepatocellular carcinoma cell line |
| BGC-823 | human gastric carcinoma cell line |
| BT-474 | human breast carcinoma are characterized by the overexpression of human epidermal growth factor receptors 2 (HER-2) and estrogen receptors (ER) |
| C4H | cinnamate 4-hydroxlyase |
| C6 | rat glioma cell line |
| Caco2 | human colorectal adenocarcinoma cells |
| Calu-3 | human lung cancer cell line |
| CCHRC5 | AUXB1 cells resistant to doxorubicin |
| CCRF-CEM | leukemia cell line |
| CD44 | cell-surface glycoprotein |
| CDK2 | Cyclin-dependent Kinase 2 |
| CEM | line of lymphoblastic cells originally derived from a child with acute lymphoblastic leukemia |
| CEM/C2 | camptothecin (CPT) resistant derivative of the human T cell leukemia cell line CCRF-CEM |
| CFU-GM | granulocyte–macrophage progenitor (GMP) |
| cIAP2 | baculoviral IAP repeat-containing protein 3 |
| c-Jun | proto-oncogene, transcription factor AP-1 |
| Colon-38 | human colon cancer cell line |
| COX-2 | cyclooxigenase-2 |
| DLD-1 | human colon cancer cell line |
| DOT1L | disruptor of telomeric silencing-1 like |
| DU-145 | human prostate cancer cell line |
| EA.hy926 | human umbilical vein endothelial cells |
| ECM | Extracellular Matrix |
| ECV-304 | human umbilical vein endothelial cells |
| EGFR-TK | Epidermal Growth Factor Receptor Tyrosine Kinase |
| eNOS | Nitric Oxide Synthase, endothelial |
| ERK | Extracellular signal-Regulated Kinases |
| GXF251L | human gastric carcinoma cells |
| H-125 | human lung cancer cell line |
| H22 | murine hepatic carcinoma cell line |
| H2887 | non-small-cell lung cancer cell line |
| H460 | large cell lung cancer cell line |
| H460/MX20 | large cell lung cancer cell line, derived from H460, mitoxantrone induced ABCG2-overexpressing cells |
| HaCaT | human keratinocyte cells |
| HCC | hepatocellular carcinoma |
| HCT116 | human colon cancer cell line |
| HCT-15 | human colon adenocarcinoma cell line |
| HCT-8 | human ileocaecal adenocarcinoma cell line |
| HDAC | histone deacetylase |
| HeLa | human cervical cancer cell line |
| HELF | embryo lung fibroblasts |
| Hep3B | human hepatoma cell line |
| HepG2 | human hepatoma cell line |
| HIF-1α | hypoxia-inducible factor 1-alpha |
| HL-60 | leukemia cells |
| HT-1080 | fibrosarcoma cell line |
| HT-29 | human colon cancer cell line |
| Huh-7 | human hepatoma cell lines |
| HUVEC | human endothelial cells |
| IFN-γ | Interferon gamma |
| IGF-1R | Insulin-like Growth Factor 1 Receptor |
| IKK | IκB kinase |
| K562 | human myelogenous leukemia cells |
| KB | epidermoid carcinoma cell lines |
| KBv200 | epidermoid carcinoma cell lines, multi-drug resistant (MDR) cell line |
| L1210 | leukemia cells |
| L5178Y | human leukemia monocytic cell line |
| LNCaP | androgen-sensitive human prostate adenocarcinoma cell line |
| LoVo | human colon cancer cell line, supraclavicular lymph node metastasis |
| LXF529L | lung cancer cell line |
| MAPK | mitogen-activated protein kinase |
| MARCHF1 | E3 ubiquitin-protein ligase MARCHF1 |
| MAXF401NL | human mammary cancer cell line |
| MCA | Mycothiol-S-conjugate Amidase |
| MCF-7 | human breast cancer cell line |
| MCF-7/ADR | Adriamycin-resistant human breast cancer cell line |
| MDA-MB-231 | epithelial, human breast cancer cell line |
| MEL28 | human melanoma cell line |
| MEXF462NL | human melanoma cell line |
| MITF | microphthalmia-associated transcription factor |
| MMP3 | Matrix Metalloproteinase-3 |
| MRC-5 | normal fibroblast cell line |
| mTOR | Mammalian Target of Rapamycin |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, reagent |
| NCI-H460 | human lung carcinoma epithelial cells |
| NDEA | N-nitrosodiethylamine |
| Neuro-2a | neuroblastoma cell line |
| NF-κB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NIH-3T3 | murine fibroblast cell line |
| NIK | NF-κB inducing kinase |
| Notch2 | Neurogenic Locus Notch Homolog Protein 2 |
| NSCLC-N6 | non-small cell lung cancer cell line |
| Oct4 | Octamer-binding transcription factor 4 |
| OVCAR-5 | human epithelial ovary carcinoma cell line |
| P-338 | sensitive murine leukemia cells |
| p38 | mitogen-activated protein kinases |
| P-388 | bipotential murine pre-B cell lymphoma |
| P388CPT5 | murine leukemia cells resistant to the reference topoisomerase I poison camptothecin (CPT) |
| p70S6K | ribosomal protein S6 kinase beta-1 |
| PAL | Phenylalanine Ammonia-Lyase |
| PANC-1 | human pancreatic cancer cell line |
| PARP | Poly (ADP-ribose) Polymerase |
| PAXF1657L | human pancreatic tumor cell line |
| PC3 | bone metastasis of a grade IV prostatic adenocarcinoma cell line |
| PCNA | proliferating cell nuclear antigen |
| PI3K | Phosphoinositide 3-Kinase |
| PKS | Polyketide Synthase |
| Rac1 | Ras-related C3 botulinum toxin substrate 1 |
| RAF | Rapidly Accelerated Fibrosarcoma, protein kinase |
| RAS | Rat Sarcoma Virus, GTP-ase |
| RD | human rhabdomyosarcoma cell line |
| Reg3A | regenerating family member 3 alpha |
| Reg3g | regenerating islet-derived protein 3 gamma |
| RhoGDI2 | Rho GDP dissociation inhibitor 2 |
| RKO | colon carcinoma cell line |
| ROS | Reactive Oxygen Species |
| RXF486L | human renal cancer cell line |
| S1 | human colon cancer cell line |
| S1-M1-80 | human colon cancer cell line, derived from S1 cells, mitoxantrone-selected ABCG2-overexpressing cells |
| SHG-44 | human glioma cell line |
| SH-SY5Y | cell line human neuroblast from neural tissue |
| SJCRH30 | rhabdomycosarcoma cancer cell line |
| SKBR3 | human breast cancer cell line, hypertriploid |
| SK-Hep1 | human hepatic adenocarcinoma cell line |
| SKOV3 | ovarian carcinoma cells |
| SLUG | transcription factor (SNAI2) |
| SNU638 | human stomach carcinoma cell line |
| Sox2 | (sex determining region Y)-box 2, trancription factor |
| Src | proto-oncogene tyrosine-protein kinase Src |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| SW1990 | spleen metastasis of a grade II pancreatic adenocarcinoma |
| SW480 | primary colon adenocarcinoma cell line |
| TAL | Tyrosine Ammonia Lyase |
| THP-1 | human leukemia monocytic cell line |
| TIMP-1 | TIMP Metallopeptidase Inhibitor 1 |
| TLR-4 | Toll-like receptor 4 |
| TNF-α | Tumor Necrosis Factor alpha |
| TOP-2 | DNA topoisomerase 2-alpha |
| TRP-1 | tyrosinase and tyrosinase-linked proteins |
| TRP-2 | tyrosinase and tyrosinase-linked proteins |
| U251 | glioblastoma-derived human cell line |
| U87 | human primary glioblastoma cell line, synonym: U87-MG |
| V79 | chinese hamster fibroblasts |
| VDAC1 | Voltage-dependent Anion-selective Channel 1 |
| VEGF | Vascular Endothelial Growth Factor |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| WAVE2 | Wiskott–Aldrich syndrome protein family member 2 |
| WST-1 | cell proliferation reagent |